Radspherin
Phase 2Recruiting 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Peritoneal Carcinomatosis
Conditions
Peritoneal Carcinomatosis, Ovarian Cancer
Trial Timeline
Jun 15, 2024 → Feb 28, 2031
NCT ID
NCT06504147About Radspherin
Radspherin is a phase 2 stage product being developed by Oncoinvent for Peritoneal Carcinomatosis. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06504147. Target conditions include Peritoneal Carcinomatosis, Ovarian Cancer.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06504147 | Phase 2 | Recruiting |
| NCT03732768 | Phase 1 | Active |
| NCT03732781 | Phase 1/2 | Completed |
Competing Products
20 competing products in Peritoneal Carcinomatosis